In the Register
r/PeterAttia
reddit/@peterattia
Across 25 decoded pieces of advice. This scores the state of the evidence behind what they say — not them, and not their honesty. Good creators cover contested ground; that shows up here as mixed.
What Noli has graded
The arrival of orally administered PCSK9 inhibitors represents a major advancement in managing cholesterol and lipoprotein(a), offering a potential alternative to statins for individuals sensitive to side effects or seeking more targeted treatment options.
Noli's read
The significant reduction of ApoB and LDL by this new class is well documented in early-phase clinical trials, confirming their biological efficacy (source: phase 2/3 trials on PCSK9 inhibitors). The effect on Lp(a), while promising, is based on preliminary data that require long-term confirmation to validate a real clinical benefit. It is important to note that while replacing statins is a popular hypothesis, statins remain the robust standard of care with decades of data on the prevention of cardiac events (meta-analyses on cardiovascular risk reduction). The idea that these pills outperform injections is appealing for convenience, but the lack of long-term cardiovascular (CV) outcomes trial results before 2029 suggests caution. The community is converging on technological enthusiasm while debating practical aspects such as cost and adherence compared to current options.
mixedthe postr/PeterAttia
The consumption of saturated fats may not be directly responsible for heart disease or increased mortality, challenging traditional dietary recommendations.
Noli's read
The community is deeply divided, oscillating between skepticism regarding the authors' conflicts of interest and a questioning of established nutritional dogmas. Scientifically, meta-analyses on the subject (such as the one mentioned, often criticized for its methodology in publications like the BMJ) show mixed results, as they aggregate older studies using trans-fat-rich margarines, which skews the findings. Current research, notably work on ApoB (often cited by Peter Attia), suggests it is more relevant to focus on individual blood lipid markers rather than the isolated consumption of a single macronutrient. It is widely accepted that overall diet quality and personal metabolic response take precedence over the demonization of a single type of fat. In sum, the idea that saturated fats are completely neutral is considered an oversimplification by the majority of contemporary experts.
mixedthe postr/PeterAttia
Lifestyle changes and weight loss are not always sufficient to correct a lipid profile, especially when significant genetic factors are present; pharmacology (statins and ezetimibe) then becomes an essential lever for achieving optimal health targets.
Noli's read
The community strongly converges on the idea that while lifestyle improves overall metabolic parameters, it is ineffective against certain genetic predispositions (such as elevated Lp(a) or APOE variants), which require medical intervention. Scientific literature confirms that genetic hypercholesterolemia is largely unresponsive to lifestyle changes (meta-analysis, Journal of the American College of Cardiology). It is accurate that rapid weight loss can transiently increase circulating cholesterol (due to the fat mobilization effect), but a very high Lp(a) level remains a persistent independent risk marker (observational studies, Lancet). The efficacy of the statin and ezetimibe combination in reducing ApoB and LDL is solidly established by randomized clinical trials (RCTs), demonstrating synergy superior to monotherapy. Potential exaggeration lies in dose management, as members often suggest fine adjustments that only a physician should validate. Finally, the idea that medication replaces effort is a shortcut: success here relies on the combination of a restored metabolism (weight loss) and targeted cardiovascular protection.
holds upthe postr/PeterAttia
The community advocates for the proactive use of statins as an essential, long-term strategy for cardiovascular health, often as a complement to active lifestyle habits.
Noli's read
Science strongly confirms that statins reduce the risk of major cardiovascular events by lowering LDL cholesterol, a fact supported by numerous meta-analyses and randomized controlled trials (RCTs). The concept that statins act over the long term to protect future health is consistent with clinical evidence. Regarding complementary inputs, studies confirm that soluble fibers, such as psyllium, can contribute to a modest reduction in LDL, and regular physical activity is a recognized pillar for improving lipid profiles and metabolic health. However, viewing the statin as a 'secondary defense' after exercise is a nuanced perspective: for high-risk individuals, the statin often remains the primary lever, rather than an accessory one. There are reported side effects (muscle pain, slight risk of diabetes), but these are often exaggerated in public perception relative to the demonstrated cardiovascular benefits. The forum shows a strong convergence toward the acceptance of these treatments, viewing them as pragmatic preventive tools.
holds upthe postr/PeterAttia
The community highlights the importance of lowering LDL cholesterol levels (via statins) for cardiovascular health, while debating the reliability of cholesterol measurements and the distinction between the simple reduction of a biological marker and the actual prevention of cardiac incidents.
Noli's read
The community is converging toward a strong consensus: lowering LDL-C is a key strategy for heart health, a position supported by a vast body of scientific literature, notably major meta-analyses (e.g., Cholesterol Treatment Trialists' Collaboration) confirming that every reduction in LDL decreases the risk of major cardiovascular events. The forum's observation regarding the influence of meals on measurements is scientifically grounded, as post-prandial triglycerides can indeed skew the LDL calculation, hence the recommendation for direct or fasting measurements. However, the skepticism expressed regarding the fact that lowering the number does not mechanically guarantee the absence of incidents is a crucial distinction: LDL is a major risk factor, but not the only one. While the causal role of LDL is established by Mendelian randomization studies (strong evidence), the community correctly notes that cardiovascular health is multifactorial and cannot be reduced to an isolated value. There is no disagreement on the utility of statins, but there is a welcome vigilance regarding the interpretation of data.
holds upthe postr/PeterAttia
An athletic physical appearance and successful weight loss via a low-carbohydrate diet can mask a significant degradation in cardiovascular health markers, notably a concerning rise in ApoB and LDL cholesterol, often caused by an excess of saturated fats.
Noli's read
The community strongly converges on the idea that the mirror is a misleading indicator and that blood lipids must be monitored, regardless of a diet's success on the scale. Research broadly supports that ApoB is a robust predictor of atherosclerotic risk; Mendelian randomization studies (e.g., Ference et al., JAMA Cardiology) show a linear causal relationship between cumulative exposure to ApoB and heart disease. The phenomenon observed in the author corresponds to the so-called 'Lean Mass Hyper-Responder' (LMHR) phenotype, where carbohydrate restriction coupled with high saturated fat intake increases VLDL production and, by extension, ApoB. While some ketogenic diet advocates debate the danger of these spikes, the current scientific consensus remains cautious, considering that the accumulation of lipids in the arteries is a long-term process. Exaggeration sometimes lies in the panicked fear of an isolated measurement, when it is chronic exposure that matters, but the advice to moderate saturated fats in favor of unsaturated fats is well-supported by general nutritional guidelines.
holds upthe postr/PeterAttia
Using very low doses of GLP-1 receptor agonists (medications typically intended for metabolic conditions) could provide health benefits, such as a reduction in inflammation or the control of addictions, independently of weight loss.
Noli's read
The community is divided: while some view these molecules as a lever for optimization, others warn of the real risk of muscle loss (sarcopenia), a pillar of long-term vitality. Scientifically, the anti-inflammatory and neurological benefits of GLP-1 are documented in preclinical studies and observational analyses (Source: Nature Medicine), but their off-label use in lean individuals remains speculative. It is proven that these substances reduce appetite, which, in a person without excess weight, can lead to involuntary protein malnutrition and therefore to a loss of muscle mass that is difficult to compensate for (Source: RCTs on weight maintenance, New England Journal of Medicine). The idea that these benefits can be dissociated from weight loss remains a hypothesis: it is complex to distinguish the direct effects of the molecule from those linked to changes in dietary habits. Finally, the use of these molecules for 'longevity' without metabolic pathology lacks robust clinical evidence and involves documented risks, particularly digestive and metabolic. The community consensus is mixed, oscillating between enthusiastic curiosity and clinical caution regarding potential side effects.
overstatedthe postr/PeterAttia
To optimize cardiovascular health, it is preferable to monitor ApoB rather than conventional LDL cholesterol, as this indicator more accurately reflects the actual number of particles capable of creating arterial deposits, and its reduction primarily relies on adjusting dietary fats, fiber intake, and, if necessary, targeted pharmacological interventions.
Noli's read
The scientific consensus strongly supports that ApoB is a superior cardiovascular risk marker to LDL-C, as it measures the total concentration of atherogenic particles (meta-analyses, expert consensus, e.g., European Atherosclerosis Society). Replacing saturated fats with unsaturated fats to reduce ApoB is a well-established recommendation in randomized controlled trials. The use of soluble fibers to promote bile acid excretion is also validated by observational and clinical evidence. Regarding treatments, the efficacy of statins and PCSK9 inhibitors is extensively documented through large phase 3 clinical trials. The recent addition of GLP-1/GIP receptor agonists (such as retatrutide) mentioned by the community is a promising emerging path showing a significant reduction in ApoB, although the effect is likely linked to weight loss and overall metabolic improvement rather than a specific direct action. The community shows a strong technical convergence around these strategies, treating ApoB as the central lever for longevity.
holds upthe postr/PeterAttia
The community notes that when lifestyle adjustments are insufficient to reduce ApoB levels, the use of statins, even at low doses, constitutes a rapid and effective lever, sometimes performing better than nutritional interventions alone.
Noli's read
Scientific consensus widely supports that statins are the standard treatment for lowering ApoB, a key marker of cardiovascular risk, as confirmed by numerous meta-analyses (e.g., Cholesterol Treatment Trialists' Collaboration). It is established that individual response to statins varies, which validates the idea that some people can achieve excellent results with less 'hyped' molecules like simvastatin. However, the 'recommendation' aspect should be nuanced: while efficacy is well-documented (high-level evidence), the choice of molecule depends on the tolerance profile. The risk of hepatic or muscular side effects mentioned by a user is a documented clinical reality, requiring regular monitoring (observational studies and clinical trials). The notion that medication takes precedence over diet in certain cases is accurate for the specific management of LDL/ApoB cholesterol, although lifestyle remains crucial for overall health. The community is very convergent here, celebrating therapeutic success while cautiously recalling the need for biological monitoring.
holds upthe postr/PeterAttia
Oral vitamin D supplementation is largely ineffective for preventing chronic diseases in healthy individuals, suggesting that the benefits observed in observational studies are likely related to sun exposure or a healthy lifestyle rather than the intake of capsules.
Noli's read
The community is converging toward marked skepticism regarding vitamin D supplements for general health, clearly distinguishing between targeted treatment for osteoporosis and preventive supplementation. Research supports this skepticism: large randomized clinical trials (RCTs), such as the VITAL study (published in the NEJM), show that supplementation does not significantly reduce the risk of cancer or cardiovascular diseases in healthy adults. The 'marker rather than driver' explanation is common: low levels may reflect poor general health or a lack of outdoor activity, rather than being a direct cause of disease. The idea that sun is superior to supplements remains a hypothesis without solid proof of a distinct biological mechanism that would be more beneficial. Finally, the scientific literature confirms that clinical utility is mainly limited to deficient populations or those with confirmed bone fragility, where supplementation, often combined with calcium, shows modest efficacy.
overstatedthe postr/PeterAttia
The community is questioning the relevance and safety of highly restrictive or supplement-heavy longevity protocols, particularly the low carbohydrate intake and high doses of dietary supplements advocated by certain media figures.
Noli's read
The debate concerns the gap between recommendations based on mechanistic models (supplements, strict restriction) and epidemiological observations. Regarding carbohydrate restriction, observational studies on Blue Zones (e.g., Blue Zones, Dan Buettner, cohort studies) show, on the contrary, that diets rich in complex carbohydrates and legumes are associated with high longevity. For supplements like NR (nicotinamide riboside), current research (meta-analyses on NAD+ precursors) remains mixed in humans, suggesting potential benefits that are still limited by a lack of robust long-term clinical evidence. The 10g dose of creatine is also noted as being well above the standard requirements validated by RCTs (often 3-5g). Finally, the use of personal protocols by wellness influencers is perceived by many as a risky approach lacking rigorous scientific validation. The community is generally divided, oscillating between scientific skepticism and distrust of advice originating from podcasts.
mixedthe postr/PeterAttia
The central idea is that very short bursts of vigorous physical activity (VILPA) offer disproportionate protection against major causes of mortality, making every minute of sustained effort much more efficient than long periods of light or moderate movement.
Noli's read
The community is skeptical and divided, highlighting the limits of statistical extrapolation when faced with biological reality. The mentioned study (based on UK Biobank data, published in Nature Medicine) is observational: it shows a strong correlation between short bursts of intense activity and a reduction in risks, but does not prove that these minutes mechanically replace hours of light activity. It is scientifically exaggerated to say that one minute of intense effort is exactly equivalent to one hour of walking, as these activities engage different physiological systems (cardiorespiratory capacity vs. basal metabolism). The notion of 'zone 2' as being systematically 'vigorous' is also contested and depends heavily on the precision of the accelerometers used, which may underestimate sports such as cycling. While the beneficial signal of intensity is validated by HIIT literature (meta-analyses on metabolic health improvement), the '1 minute = 1 hour' shortcut remains a simplistic interpretation of complex statistical data.
overstatedthe postr/PeterAttia
The community is discussing a study suggesting that at an equivalent volume of physical activity, men may obtain fewer heart health benefits than women, potentially implying a need to adjust exercise recommendations based on biological sex.
Noli's read
This discussion is based on an observational study published in the Journal of the American College of Cardiology, which tracked a large cohort over several years. The data show a statistical correlation where women achieve a reduction in cardiac risk with a lower volume of moderate activity than men. It is important to note that this is an observational study, which means it shows an association but does not prove a direct causal link. The criticisms raised by users, such as the need for studies using Mendelian randomization, are relevant because they would help better isolate genetic factors from lifestyle habits. The idea that men 'must' do twice as much exercise is a simplified interpretation that obscures the complexity of the underlying physiological mechanisms. The community generally agrees that standardized recommendations are imperfect and advocates for a more personalized approach to health.
mixedthe postr/PeterAttia
The community suggests that certain anxiety medications, particularly serotonin-norepinephrine reuptake inhibitors (SNRIs), may artificially elevate resting heart rate and limit training capacity, thereby skewing fitness data such as VO2 max.
Noli's read
The link between medications acting on norepinephrine and an increase in heart rate is a known and documented pharmacological effect (source: official product inserts for duloxetine-type medications, evidence: clinical pharmacokinetics). The claim that certain antidepressants could alter mitochondrial function is also a subject of preclinical study (source: basic research articles in neuropharmacology, evidence: in vitro/animal model studies), but these results are not directly transposable to claim a measurable decrease in performance in humans. The idea that connected devices can reveal previously invisible side effects is an increasingly common anecdotal observation in the wellness community, although the precision of these devices remains limited. It is important to note that the correlation between an elevated heart rate and calculated VO2 max is complex, as watch algorithms often use heart rate to estimate physical fitness. The community strongly converges on the idea that medications are not neutral solutions and that personal monitoring is essential, while acknowledging the limitations of smartwatch data.
mixedthe postr/PeterAttia
Optimal longevity does not depend on overpriced luxury medical services or hyper-monitoring through frequent testing, but is built primarily through accessible pillars: regular exercise (strength and endurance), proper nutrition, and healthy lifestyle habits, for a fraction of the cost of so-called "concierge" protocols.
Noli's read
The community largely agrees that extreme medicalization and repeated testing (such as quarterly VO2 max tests) are superfluous. Research supports this skepticism: while monitoring certain biomarkers (lipids, blood pressure) is validated by meta-analyses to reduce cardiovascular risk, excessive screening in asymptomatic individuals can lead to false positives and unnecessary anxiety (observational studies on overdiagnosis, BMJ). Physical exercise, by contrast, is robustly supported by randomized controlled trials (RCTs) and meta-analyses as the most powerful lever for increasing healthy life expectancy. The forum's consensus here is very strong: it denounces longevity marketing in favor of a "low-cost" approach based on movement. The use of "off-label" medications (such as tadalafil or sartans) mentioned by some members remains a gray area without robust clinical consensus for the general healthy population.
holds upthe postr/PeterAttia
The community is debating the utility of brushing teeth immediately upon waking, with the consensus suggesting that the essentials actually lie in the consistency of brushing, rigorous use of dental floss, and the long-lasting application of fluoride, rather than in the precise timing relative to breakfast.
Noli's read
The debate highlights a distinction between extreme optimization and the basics of oral hygiene. Evidence from systematic reviews (such as Cochrane) confirms that flossing is crucial for gum health, an element often underestimated compared to simple brushing. Regarding fluoride, the evidence is robust (meta-analyses on dental caries): it is prolonged exposure to fluoride that protects enamel, hence the recommendation not to rinse one's mouth after brushing. The idea of brushing before breakfast to protect enamel against the acidity of food is based on coherent biological logic, although clinical studies specifically comparing 'before vs. after' with long-term health outcomes are limited. The argument that immediate brushing is indispensable is often perceived by members as a marketing exaggeration, as they prioritize interventions with proven clinical impact. The community is sharply divided: a large majority rejects the obsessive approach of certain influencers in favor of conventional dental practices.
mixedthe postr/PeterAttia
The use of statins is strongly recommended to reduce circulating lipids (ApoB/LDL) and prevent cardiovascular diseases, even in apparently healthy individuals, because genetics often take precedence over lifestyle in cholesterol control.
Noli's read
The community is converging toward a pragmatic acceptance of statins as a longevity tool, despite persistent cultural distrust linked to a fear of side effects or a rejection of medication dependency. Scientifically, the efficacy of statins in reducing major cardiovascular events is solidly established by numerous meta-analyses (e.g., Cholesterol Treatment Trialists' Collaboration). The link between the reduction of ApoB and the decrease in atherosclerosis risk is a robust medical consensus. Exaggeration often lies in the fear of muscle side effects, which, while real for a minority (confirmed by RCTs), are sometimes overestimated relative to the protective benefit, or confused with signs of natural aging. The idea that statins are a direct cause of diabetes is a subject of debate, with evidence suggesting a slightly increased risk, but one that is largely offset by the reduction in overall cardiovascular risk. Finally, the use of low doses combined with other molecules (such as ezetimibe) to minimize discomfort is a strategy validated by current clinical practice.
holds upthe postr/PeterAttia
The community is concerned about the reliability of nutritional labeling for processed protein bars, suggesting that influencer-endorsed products may have significant discrepancies between actual content and displayed values, making the consumption of whole, unprocessed foods a safer choice.
Noli's read
The debate centers on label accuracy, a subject documented by organizations such as ConsumerLab (independent testing), which regularly highlights discrepancies in the supplement and snack industry. It is scientifically established, through observational studies and laboratory analyses, that processed foods can vary in actual composition compared to nutritional declarations, often due to industrial processes or controversial caloric calculation methods (such as those for so-called non-digestible fats). The user argument regarding the difference between laboratory calorimetry (which burns everything) and human digestion (which partially absorbs) is a legitimate question in nutrition, but the scale of the discrepancies reported here (over 500% for lipids) remains outside acceptable tolerance standards. It is common for highly processed products to lack transparency, which validates caution toward influencer marketing. The community is heavily polarized by disappointment and the questioning of the integrity of the public figures involved in these brands, converging toward increased distrust of ultra-processed products.
holds upthe postr/PeterAttia
Permanent genetic modification (base editing) targeting the PCSK9 gene to drastically reduce LDL cholesterol represents a potential therapeutic revolution, capable of replacing chronic pharmaceutical management with a single, definitive solution.
Noli's read
The community is showing cautious but notable enthusiasm for this technology, which is viewed as a major paradigm shift despite the standard uncertainties of clinical development. Scientifically, PCSK9 gene inhibition is a validated strategy already leveraged by monoclonal antibodies and small interfering RNAs (evidence: RCT clinical trials, cardiological consensus). Base editing to 'turn off' this gene is an innovative approach that has shown promising early results in phase 1 studies (Verve Therapeutics), but long-term data on human safety and efficacy are severely lacking. The idea that modifying a gene is risk-free is exaggerated, as every genetic intervention carries risks of off-target effects and unforeseen metabolic consequences over a lifetime, which justifies the need for large-scale clinical studies. It is also important to note that PCSK9 is not responsible for all cholesterol management, and the assertion that this therapy alone would eliminate atherosclerosis is optimistic speculation. The community converges on the idea that this technology is a fascinating advancement, while vigorously debating safety risks and commercial motivations.
mixedthe postr/PeterAttia
The community agrees that a significant reduction in LDL cholesterol (the "bad" cholesterol) is a priority health objective, achievable primarily through strict dietary adjustments, notably by significantly increasing fiber intake and drastically reducing saturated fats.
Noli's read
Science robustly validates the idea that high consumption of soluble fiber helps lower LDL cholesterol by limiting its absorption, as shown by several meta-analyses (e.g., Everson et al.). Reducing saturated fats in favor of unsaturated fats is also a pillar recognized by health organizations for improving lipid profiles (RCT/randomized clinical trials). However, the central role of LDL is currently nuanced in scientific literature by ApoB (apolipoprotein B), which is considered by many experts to be a more precise marker of cardiac risk, a point that the community aptly raises. The idea that this process necessarily requires years is sometimes contradicted by physiology, as the renewal of blood cholesterol is quite rapid, suggesting that changes can produce results much sooner. Finally, it is important to note that genetics play a major and unpredictable role in these levels, which a purely dietary approach can sometimes underestimate. The community strongly converges around the importance of these metrics and a proactive, data-driven approach.
mixedthe postr/PeterAttia
Ashwagandha is widely considered a powerful tool for managing stress, improving sleep quality, and optimizing recovery, although its impact varies significantly between individuals, with some reporting a sense of apathy or notable adverse effects.
Noli's read
Research, particularly through systematic reviews and meta-analyses (e.g., Examine.com, Journal of Clinical Medicine), confirms that ashwagandha possesses adaptogenic properties capable of reducing cortisol levels and improving perceived stress and anxiety scores. However, the claim that it acts primarily on the thyroid is an oversimplification: while the herb can stimulate thyroid activity, its effects on well-being are systemic and relate to overall hormonal regulation. Cases of apathy or emotional blunting reported by the community are not yet well documented clinically, but they are consistent with a potentially excessive reduction in cortisol or prolonged neurochemical modulation. The lack of standardization in preparations (root vs. leaf extracts, concentrations) partially explains the divergence in lived experiences. The community is deeply divided, oscillating between enthusiasm for its measurable benefits on sleep and increased caution regarding unexpected and individual side effects.
mixedthe postr/PeterAttia
The community is exploring the possibility of increasing testosterone levels through lifestyle changes or natural dietary supplements, rather than through direct hormonal intervention.
Noli's read
The discussion reflects a desire to optimize hormones naturally, but the evidence behind the suggested methods is uneven. The use of supplements like Fadogia Agrestis is flagged by some members for potential risks of hepatic and renal toxicity, highlighting a lack of long-term human safety data (case study/toxicology reports). The idea that 'natural' testosterone levels are superior to those of hunter-gatherer populations is corroborated by anthropological research such as that of Herman Pontzer (author of 'Burn'), suggesting that our current levels may not be the optimal biological norm. The impact of medications like finasteride is debated, illustrating the complexity of individual hormonal conversion. Finally, the use of supplements like boron to increase free testosterone relies on small-scale studies (preliminary RCTs), often insufficient to generalize robust efficacy. The community is divided between enthusiasm for self-experimentation and caution regarding toxicological risks.
mixedthe postr/PeterAttia
The community rejects the idea that all-in-one 'superfood' powders can replace the actual consumption of fruits and vegetables, viewing these products as expensive, underdosed multivitamins whose promotion is largely driven by financial interests.
Noli's read
The idea that a powdered supplement can be a substitute for a diet rich in whole plants is not supported by nutritional science. Meta-analyses (e.g., Cochrane) indicate that while supplements can address specific deficiencies, they do not replicate the complex synergy of fiber, phytonutrients, and bioactive compounds found in whole foods. Experts often point out that the bioavailability and dosage in these proprietary blends are frequently insufficient to provide a real metabolic benefit. The community's skepticism is reinforced by the business model of these products, where a large portion of the price funds marketing rather than nutritional quality. Current scientific literature does not validate the use of these powders as 'health insurance' for a person who already has a balanced diet. The community strongly converges toward a critical view, citing a lack of transparency and an unfavorable cost-benefit ratio.
holds upthe postr/PeterAttia
The community validates the idea that a structured approach, based on the quantification of biological data and the rigorous tracking of personalized health goals (“Medicine 3.0”), is the primary lever for optimizing longevity and preventing chronic diseases.
Noli's read
The thread shows a total convergence of the community around the practical application of Peter Attia’s recommendations, based on the optimization of metabolic and cardiovascular markers. Scientifically, the “precision medicine” approach is supported by observational studies showing a strong correlation between the proactive management of lipids (ApoB), blood pressure, and a reduction in cardiovascular risk (Journal of the American College of Cardiology). Work on muscle mass and metabolic health (Zone 2, VO2 max) is supported by meta-analyses linking good physical condition to a reduction in all-cause mortality. However, the risk lies in extrapolation: while tracking data is useful, research remains limited regarding the capacity of these isolated measures to guarantee a significant extension of lifespan in every individual. The potential exaggeration lies in the belief that strict control of every biomarker is sufficient to 'hack' aging. In short, the method is solid for risk management, but its complexity can lead to over-optimization that is sometimes disconnected from overall clinical reality.
mixedthe postr/PeterAttia
The community recommends prioritizing creatine monohydrate certified as "Creapure®" to ensure optimal purity and avoid risks associated with less controlled manufacturing processes.
Noli's read
Creatine monohydrate is one of the most studied and scientifically validated supplements (systematic meta-analyses, high level of evidence) for supporting physical and cognitive performance. The Creapure® label corresponds to a German trademark known for its rigorous manufacturing processes, which reduce the risk of impurities like dicyandiamide, although most creatine monohydrates on the market are chemically nearly identical. User concern regarding the country of origin is common in the wellness community, but it is often exaggerated relative to the actual risk, as modern synthesis methods allow for high purity regardless of the production location. Third-party certifications (NSF, USP, Informed Choice) provide a much more robust indicator of quality than geographic origin alone. Utilizing independent testing services, such as ConsumerLab, is a pragmatic approach for validating the actual composition of products. The community strongly converges on a preference for Creapure® as a quality standard.
holds upthe postr/PeterAttia